FYB1 and diabetes mellitus: Previous studies suggested that ADAP deficient Treg cells mediated suppressive capacity at wild type levels when co-transferred with effector T cells into NOD/SCID mice to monitor recipients for diabetes; and ADAP deficient Treg cells inhibited TCR-stimulated effector T cell proliferation in vitro as that by wild type Treg cells [32].